About Trans Ova Genetics
Trans Ova Genetics is a company based in Sioux Center (United States) founded in 1980, and was acquired by Precigen in July 2014. Reproduction and breeding services for livestock genetics are provided. Trans Ova Genetics has raised $9 million across 1 funding round from investors including Precigen and Iowa Values Fund. The company has 1 employees. Trans Ova Genetics has completed 1 acquisition, including ViaGen. Its Indian entity Trans Ova Laboratories India Private Limited reported revenue of ₹7.1 Lakh. Trans Ova Genetics offers products and services including In Vitro Fertilization and Embryo Transfer.
Company details
Trans Ova Genetics was established in 1980 in Sioux Center, United States, within the livestock agribusiness sector. Services focused on genetic preservation and reproduction for ruminants are delivered, including embryo transfer, in vitro fertilization, sexed semen, cryo-preservation for cloning, and related consultations. Operations are managed through regional centers in Iowa, Texas, Maryland, and Missouri, supplemented by satellite facilities.
- Headquarters Sioux Center, United States
- Employees 1
- Stage Acquired
- Website transova.com
- Social LinkedIn X Facebook
- Acquired by Precigen (Jul 2014)
- Legal Name Trans Ova Laboratories India Private Limited
- Date of Incorporation 14 Aug, 2020
- Jurisdiction Delhi, India
- Indian entity revenue₹7.1 Lakh
FY 2023
- Indian entity net profit₹5 Lakh
FY 2023 · 70% margin
- Indian entity EBITDA₹6.7 Lakh
FY 2023 · 95% margin
- Total Equity Funding$9M (USD)
in 1 rounds
- Latest Funding Round$9M (USD), Private Equity Round
Aug 2003
- InvestorsPrecigen
& 1 more
- Employee Count1
- Investments & Acquisitions
- Acquired byPrecigen
(Jul 2014)
Associated legal entities of Trans Ova Genetics
Trans Ova Genetics operates through Trans Ova Laboratories India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Trans Ova Laboratories India Private Limited CIN U01100DL2020FTC368066 | Active | 14 Aug 2020 | Delhi, Delhi | ₹0.1 Cr | 3 | View details |
Products & Services of Trans Ova Genetics
Trans Ova Genetics offers a comprehensive portfolio of products and services, including In Vitro Fertilization and Embryo Transfer.
In vitro fertilization is offered for advancing genetics in animals such as dairy and beef cattle
Embryo transfer is utilized to multiply herd genetics and achieve breeding objectives in livestock
Funding Insights of Trans Ova Genetics
Trans Ova Genetics has successfully raised a total of $9M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $9 million completed in August 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9M
- Total Rounds 1
- Last Round Private Equity Round — $9M
- First Round $9M
(Aug 2003)
- Investors Count 1
All 1 funding rounds of Trans Ova Genetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2003 | $9M | Private Equity Round | – | Iowa Values Fund | – |
2 investors in total: 2 institutional.
Investors in Trans Ova Genetics
Trans Ova Genetics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Precigen and Iowa Values Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| iowavaluesfund.tcc.mode | ||||
Gene and cell therapy biopharmaceutical company focused on immuno-oncology, autoimmune, and infectious diseases | 1998 | precigen.com | Germantown, United States |
Investor details for Trans Ova Genetics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Trans Ova Laboratories India Private Limited (Trans Ova Genetics)
Trans Ova Laboratories India Private Limited is the primary company behind Trans Ova Genetics. The board of Trans Ova Laboratories India Private Limited currently have 3 directors; the longest-serving is David Charles Faber, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| David Charles Faber DIN 08835291 | Director | 14 Aug 2020 | 6 yrs 2 mo | Trans Ova Laboratories India Private Limited |
| Katherine Lynn Jauert Jess DIN 08835292 | Director | 14 Aug 2020 | 6 yrs 2 mo | Trans Ova Laboratories India Private Limited |
| Deepti Goyal DIN 06999872 | Director | 14 Aug 2020 | 6 yrs 2 mo | Trans Ova Laboratories India Private Limited |
People of Trans Ova Genetics
1 people are tracked at Trans Ova Genetics (1 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Troy Klimesh | Director Of Operations | Leadership |
Complete people profiles for Trans Ova Genetics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Trans Ova Genetics
Figures of Trans Ova Laboratories India Private Limited, the primary company behind Trans Ova Genetics, for FY 2023. Revenue was ₹7.1 Lakh. Net profit was ₹5 Lakh (70% margin). EBITDA was ₹6.7 Lakh (95% margin).
- ₹7.1 LakhRevenue · FY 2023
- ₹5 LakhNet profit · 70% margin
- ₹6.7 LakhEBITDA · 95% margin
- ₹72.3 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Trans Ova Laboratories India Private Limited are on its company page.
Detailed financial statements for Trans Ova Genetics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Trans Ova Genetics
Trans Ova Genetics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ViaGen.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cloning services for livestock and pets are offered by Viagen. | viagen.com | Austin, United States | 2002 | Jun 2012 | •••• |
Complete acquisition details for Trans Ova Genetics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Web traffic of Trans Ova Genetics
The website of Trans Ova Genetics (transova.com) receives about 9.6K visits a month.
- Monthly visits9.6K
▲ 8.2% vs previous month
Websites whose visitors overlap most with Trans Ova Genetics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| americangoatsociety.com | 100% | #5,393,192 | View details | ||
mn-angus.com | mn-angus.com | 100% | – | ||
bamabeef.org | bamabeef.org | 100% | #4,582,135 | – | |
| ebersale.com | 100% | View details | |||
facilitymanagement.com | facilitymanagement.com | 63% | #4,515,404 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Trans Ova Genetics
Trans Ova Genetics was founded in 1980 and raised its 1st funding round 23 years after it was founded.
Trans Ova Genetics is headquartered in Sioux Center, United States. It is registered at Sioux Center, Iowa, United States.
Trans Ova Genetics is a funded company, having raised a total of $9M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $9M, raised on Aug 2003.
Trans Ova Genetics has 1 employees.
The primary company behind Trans Ova Genetics, Trans Ova Laboratories India Private Limited, reported revenue of ₹7.1 Lakh for FY 2023.
Trans Ova Genetics was established in 1980 in Sioux Center, United States, within the livestock agribusiness sector. Services focused on genetic preservation and reproduction for ruminants are delivered, including embryo transfer, in vitro fertilization, sexed semen, cryo-preservation for cloning, and related consultations. Operations are managed through regional centers in Iowa, Texas, Maryland, and Missouri, supplemented by satellite facilities.
Trans Ova Genetics offers In Vitro Fertilization and Embryo Transfer.
Trans Ova Genetics has made 1 acquisition, including ViaGen.
Trans Ova Genetics has 2 investors. Key investors include Precigen, and Iowa Values Fund.
Trans Ova Genetics operates through Trans Ova Laboratories India Private Limited.
Yes. Trans Ova Genetics was acquired by Precigen in July 2014.
The legal entities of Trans Ova Genetics currently have 3 directors, including David Charles Faber, Katherine Lynn Jauert Jess, Deepti Goyal.